During following passages from 12 to 14 without lincomycin, mycoplasmas did not recover. These results check details showed that
we successfully eliminated mycoplasmas also from the low virulent Kuroki strain. The elimination length of Kuroki strain was longer than that of Ikeda strain probably because numbers and/or antibiotics-susceptibility of the contaminated mycoplasmas were different. For further elimination of mycoplasmas from other strains of O. tsutsugamushi, we should first evaluate a maximum concentration Selleck Fosbretabulin of lincomycin that does not influence O. tsutsugamushi-growth, and then apply it for decontamination because maximum effects against mycoplasmas are necessary to eliminate them for a short time and to avoid producing lincomycin-resistant mycoplasmas [13–15] during repeating passages. Our additional assay showed that lincomycin at 25 μg/ml did not affect the growth (the virulent strain), whereas 50 μg/ml slightly decreased
(did not inhibit) the growth in the IF assay (Table 3). Many previous reports about antibiotics-susceptibilities of isolated mycoplasmas showed that MICs of lyncomycin against M. hominis, M. fermentas and A. laidlawii, which are the major contaminants, were less than 6 μg/ml selleck inhibitor (0.025 to 6 μg/ml) [5, 16–18]. In actual, a previous report showed that lincomycin at 50 μg/ml successfully eliminated the other major contaminants of mycoplasmas, M. hyorhinis and M. hominis from cell cultures . However, a previous report showed that some isolates of M. hyorhinis were highly resistant to lyncomycin (MICs > 100 μg/ml)  and a few Bumetanide reports showed that other species of mycoplasmas but not major species of contaminants were highly resistant to lyncomycin [13, 15]. Considering these facts, lincomycin at 50 μg/ml can possibly eliminate the contaminants from many of other contaminated strains of O. tsutsugamushi, although it might not be effective for all the
cases. Table 3 The growth of O. tsutsugamushi at the various concentrations of lincomycin Concentrations of lincomycin in the culture medium 12.5 μg/ml 25 μg/ml 50 μg/ml 100 μg/ml O. tsutsugamsuhi-growtha) +++ +++ ++ – a) A virulent Ikeda strain was cultivated using L-929 cell in the culture medium containing lyncomycin at the indicated concentrations. The growth was observed by the immunofluorescent staining. Conclusions Our results showed an alternative method to eliminate mycoplasmas from the mycoplasma-contaminated strains of O. tsutsugamushi in place of in vivo passage through mice. Especially this new method works for the decontamination not only from the high virulent strain also from the low virulent strain of O. tsutsugamushi, which is difficult to propagate in mice. For further elimination, lincomycin at the limit concentration, which does not inhibit the growth of O. tsutsugamushi, can possibly eliminate most mycoplasmas from contaminated O. tsutsugamushi strains.